Background Reaching the therapeutic target of remission or low-disease activity has
improved outcomes in patients with rheumatoid arthritis (RA) significantly. The treat-to-target …

The abundance and activation of macrophages in the inflamed synovial membrane/pannus
significantly correlates with the severity of rheumatoid arthritis (RA). Although unlikely to be …

New treatment strategies have substantially changed the course of rheumatoid arthritis. Many
patients can achieve remission if the disease is recognised early and is treated promptly …

Objective The 1987 American College of Rheumatology (ACR; formerly, the American
Rheumatism Association) classification criteria for rheumatoid arthritis (RA) have been criticized …

Objectives To provide an update of the European League Against Rheumatism (EULAR)
rheumatoid arthritis (RA) management recommendations to account for the most recent …

… Burmester has received consulting fees of less than $10,000 from Schering-Plough. Dr. …
Burmester has received consulting fees of less than $10,000 from Schering-Plough. Dr. Furst …

Objective To update the European League Against Rheumatism (EULAR) recommendations
for the pharmacological treatment of psoriatic arthritis (PsA). Methods According to the …

Background Rheumatoid arthritis is a heterogeneous chronic disease, and no therapeutic
agent has been identified which is universally and persistently effective in all patients. We …

Background Cyclo-oxygenase 2 (COX2)-selective inhibitors should reduce ulcer complications
compared with non-selective non-steroidal anti-inflammatory drugs, but evidence is …

Introduction We analyzed the prevalence of cardiovascular (CV) disease in patients with
rheumatoid arthritis (RA) and its association with traditional CV risk factors, clinical features of …